首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 46 毫秒
1.
The 20th IUPAB Congress took place online, together with the annual meetings of the Brazilian Biophysical Society and the Brazilian Society for Biochemistry and Molecular Biology, from the 4th to the 8th of October, 2021. The ten keynote lectures, 24 symposia, two poster sessions, and a series of technical seminars covered the full diversity of current biophysical research and its interfaces with other fields. The event had over 1000 attendees, with an excellent gender balance. Although the Americas dominated, there were also significant numbers of participants from Europe, Asia, and Africa.

The International Union of Pure and Applied Biophysics (IUPAB) came into existence in Stockholm in 1961 and has been a member of the International Science Council since 1966 (Solomon 1968). Its overall objectives aim to foster international collaboration in all aspects of biophysics and related areas and to catalyze the advancement of basic biophysical research as well as its many applications. Although IUPAB is active on many fronts, undeniably one of its showcase events is the IUPAB Congress, traditionally organized every three years in different locations worldwide. In 2021, the event was organized and run from Brazil, albeit for the very first time in a virtual format due to travel restrictions imposed by the COVID-19 pandemic. On this occasion, the Congress was organized in conjunction with the annual meetings of both the Brazilian Biophysical Society (SBBf, in its 45th edition) and the Brazilian Society for Biochemistry and Molecular Biology (SBBq, in its 50th edition). Even with the united forces of these well-established local societies, it turned out to be a bumpy ride to bring the event to fruition.Plans for the 20th Congress began in 2016, almost immediately after the decision to hold the event in Brazil, a cause championed by the then-president of the Brazilian Biophysical Society, Marcelo Morales. The original plans had the meeting to be held in the Cidade Maravilhosa (The Wonderful City) of Rio de Janeiro in October 2020. However, it soon became apparent that the political and economic difficulties that the State of Rio was facing at the time meant that it would be wise to search for an alternative venue. The previous experience of SBBq in organizing similar events in the city of Foz do Iguaçu, on the borders with Argentina and Paraguay, made this an obvious choice. Furthermore, the natural attraction of the spectacular Iguaçu waterfalls seemed to be an ideal compensation for Sugar Loaf Mountain, Copacabana beach, and the statue of Christ the Redeemer on Corcovado Mountain.Then came the pandemic. By mid-2020, it had become apparent that there were too many unknowns to make it possible to proceed with an in-person event in October of that year. It was decided to postpone the congress to 2021 but with a firm belief that things would be “back to normal.” Sweet delusion! As 2020 turned into 2021 and the severity and longevity of the pandemic became clearer and clearer (not to mention the abysmal performance of the Brazilian government in failing to rise to the challenge), the inevitable decision was taken to transform the event into an “on-line” congress. This was a first for both the local organizers and the IUPAB.The move to an online format immediately had an impact on the organization of the Young Scientist Program. This was initially envisaged to be a combination of formal and informal activities aimed at uniting about 40 early carrier scientists and post-docs for a couple of days prior to the main event in a stimulating atmosphere conducive to networking. Skillfully conceived, organized, and executed by Eneida de Paula (Campinas) and Eduardo Reis (São Paulo), this too had to be adapted to a “virtual reality.” The successful solution turned out to be a series of fortnightly thematic webinars, including a talk from a recognized authority in the field followed by three or four short presentations from the participants themselves (Table (Table1).1). The standard was extremely high and the YSP ended up being a highly effective warm-up to the congress itself. Furthermore, there was excellent geographical diversity among the participants with Europe, Africa, Asia, the Middle East, and both North and South America represented.Table 1Young Scientist Webinar Program
DateGeneral subject areaInvited speaker
19th MayBiomimetic Structures and Systems/Multiscale Biophysics of MembranesManuel Prieto, Portugal
26th MayCell Biophysics and Phase TransitionClifford Brangwynne, USA
9th JunePlant biotechnology/Biofuels/BioenergyIgor Polikarpov, Brazil
23rd JuneApplications in Biomedical and Materials Science
7th JulyMechanisms of Membrane ProteinNatalie Strynadka, Canada
21st JulyMembrane Permeation: Channels and TransportersEduardo Perozo, USA
4th AugustBioenergetics and MetabolismAlicia Kowaltowski, Brazil
18th AugustProtein Structure to Function/Structural BiologyWah Chiu, USA
1st SeptemberComputational Biophysics and BiochemistryIngemar André, Sweden
15th SeptemberDrug Discovery and DeliveryFabio Sonvico, Italy
Open in a separate windowThe main event attracted over 1000 participants, with an excellent gender balance. Although the Americas dominated, there were also significant numbers of participants from Europe, Asia, and Africa (Fig. 1). Table Table22 gives an excellent idea of the diverse subject matter covered during the 5 days of the congress itself. As to be expected, the way in which biophysics naturally interfaces with biochemistry, molecular biology, cell biology, chemistry (including medicinal chemistry), physics, engineering, etc. was more than apparent. Nevertheless, several themes appeared to be particularly recurrent throughout the event. Notwithstanding the plethora of other topics, several main threads permeated the proceedings, and these included (1) lipids, membranes, their assembly, and dynamics; (2) bioimaging at all levels; (3) drug targets and drug development/delivery; and (4) molecular recognition including membrane/protein interactions. This special issue aims to cover the main topics of the event as comprehensively as possible in similar vein to previous efforts (Hall and dos Remedios, 2017). In over 50 articles, including reviews, commentaries, letters, and editorials, we aim to convey the full flavor of the congress. It is hoped that this will serve simultaneously as both a useful source of reference and a historical record. The short, focused review articles are all up-to-date and expected to be of particular value to a broad readership. We hope that you enjoy them as much as we have and find them to be instructive and beneficial.Open in a separate windowFig. 1Participants by continentTable 2Symposia organized during the 20th IUPAB Congress
TitleChair
Drug design and deliveryJoke Bouwstra (Leiden, Netherlands)
Protein Structure, Dynamics and FunctionRichard Garratt (São Carlos, Brazil)
Biological Photosensors and their Applications in OptogeneticsSilvia Braslavsky (MPI, Germany)
Macromolecular Machines and Switching DevicesAlejandro Buschiazzo (Montevideo, Uruguay)
RSC–Chemical BiologyRandall Peterson (Utah, USA)
Young Talent in Life Sciences (Cytiva Award)Juliana Fietto (Viçosa, Brazil)
Deforming MembranesPatricia Bassereau (Curie Institute, France)
Systems Biology and Biomarkers for Human DisordersPeter Nilson (KTH, Stockholm, Sweden)
PABMB Symposium: Metabolism and BioenergeticsAlicia Kowaltowski (São Paulo, Brazil)
BiophotonicsGeorg Wondrak/Martha Ribeiro (Arizona, USA/São Paulo, Brazil)
Microbiomes: human and environmentalLeda Vieira (Belo Horizonte, Brazil)
Molecular and Cell ImagingPaulo Bisch (Rio de Janeiro, Brazil)
Ionic Channels and Membrane TransportersJohn Baenziger (Chicago, USA)
Biomolecular Association and DynamicsPaul Whitford (Boston, USA)
Gender in ScienceCristina Nonato/David Crossman (Ribeirão Preto, Brazil/Aukland, New Zealand)
Protein Folding, Misfolding and UnfoldingVladimir Uversky (Tampa, USA)
EBSA Symposium on Translational BiophysicsAnthony Watts/Jesús Pérez-Gil (Oxford, UK/Madrid, Spain)
Autophagy: Mechanisms and ApplicationsMarcelo Mori (Campinas, Brazil)
Membrane SimulationMikko Karttunen (Ontario, Canada)
Systems Biologics: at the interface…Stephen Michnick (Montreal, Canada)
IUBMB Symposium: Science EducationManuel João Costa (U. Minho, Portugal)
Scissioning MembranesRumiana Dimova (Potsdam, Germany)
Redox BiologyRafael Radi (Montevideo, Uruguay)
Biophysics of the Immune SystemJean-Marie Ruysschaert (Brussels, Belgium)
Open in a separate windowAll of the Keynote lectures (Table (Table3)3) were very well attended. The Nobel laureate Richard Henderson set the ball rolling with a beautifully clear historical overview of how cryo-EM got to be where it is now and what we might expect for the near future. Tony Watts (the new president-elect of IUPAB) closed the event with the Avanti/IUPAB award lecture and a clear message that biophysics is not all about proteins—lipids are important (also)! Midweek, a second Nobel prize winner, Michael Levitt, gave his take on the COVID-19 pandemic by applying his talent for mathematical modeling in much the same way as he so successfully applied it to macromolecular systems in the past. At the very least, his talk gave plenty of food for thought to those who were present.Table 3Keynote speakers
SpeakerTitle
Richard Henderson (LMB, Cambridge)Impact of Single Particle Cryo-electron Microscopy on Structural Biology
Carlos Bustamante (University of California, Berkeley)Co-temporal Force and Fluorescence Measurements Reveal a Ribosomal Gear-shift Mechanism of Translation Regulation by mRNA Secondary Structures
Giorgio Trinchieri (Center for Cancer Research, NIH, Maryland)Targeting the microbiome in cancer immunotherapy
Tao Xu (Chinese Academy of Sciences)The Bei Shizhang Lecture: Cryogenic superresolution correlative light and electron microscopy on the frontier od subcellular imaging
Michael Levitt (Stanford)Lessons from 620 days Studying COVID-19
Ohara Augusto (São Paulo)Carbon Dioxide Redox Metabolites in Eustress and Oxidative Distress
Ramon Latorre (Valparaíso)Calcium-driven Voltage Sensingand the role of Charged Residues in the voltage sensor domain of BK
Angela Gronenborn (Pittsburgh)The Awesome Power of Fluorine NMR
Yoav Shechtman (Haifa)IUPAB Young Investigator Lecture: Next Generation Localization Microscopy—or How and Why to Ruin and Perfectly Good Microscope
Anthony Watts (Oxford)Avanti/IUPAB Award Lecture: Lipids are important
Open in a separate windowOverall, the sessions were very well attended with typically over 200 participants. The ease of moving from one session to another under the virtual format proved to be a notable advantage. Furthermore, since many of the talks were pre-recorded, most of the sessions kept to time rather better than is often the case at traditional events. The two poster sessions were also very well frequented, and the pre-recorded videos were generally of high quality. Approximately 10% of all poster presenters were awarded prizes during the closing ceremony, and six special prizes were generously provided by the Royal Society of Chemistry.Several special activities were held throughout the week. These included technical seminars by some of the sponsors, including Cytiva, Thermo-Fisher, and Sartorius as well as sessions devoted to Brazil-German exchange programs and one on “Gender in Science.” The latter was particularly motivational for the congress participants, whose demographic was heavily biased towards early-career scientists, post-docs, and students (Fig. 2). Biophysical Reviews organized two early-morning sessions, one of which was an editorial board meeting whilst the other was open to all interested parties and represented an opportunity to promote the journal within the community. The IUPAB held its general assembly on the 6th of October. Manuel Prieto formally took over as President with Marcelo Morales stepping down but continuing as a council member in the role of immediate Past President. Tony Watts becomes the new President Elect.Open in a separate windowFig. 2The distribution of participants according to their stage in the careerDespite the challenges of organizing a widely diverse international event online, we came away with the feeling of a mission accomplished and the hope that we will be able to meet up in person in the very near future. From the extremely high standard of the presentations and the overall satisfaction of the participants, we think it can be considered to have been a success. See you all in Kyoto!  相似文献   

2.
The Invasion of Ukraine prompts us to support our Ukranian colleagues but also to keep open communication with the Russian scientists who oppose the war.

In the eyes of the civilized world, Russia has already lost the war: politically, it is becoming ever more isolated; economically as the sanctions take an enormous toll; militarily as the losses of the Russian army mount. In contrast, the courage of Ukrainian people fighting for their independence has united the Western world that is providing enormous support for those Ukrainians who fight the Russian invasion and those who have fled their war‐torn country. Once this war is over, Ukraine will have to heal the wounds of war, reunite families, restore its economy, reestablish infrastructure, and rebuild science and education. Russia will have to restore its dignity and overcome its self‐inflicted isolation.Europe’s unity in condemning Russia’s war of aggression and showing its solidarity with Ukraine has been impressive. This includes not the least welcoming and accommodating millions of refugees. We, the scientific community in Europe, have a moral obligation to help Ukrainian students and colleagues by providing safe space to study and to continue their research. First, European research organizations and funding agencies should develop strategies to support them in the years to come. Second, efforts by EMBO, research funders, universities, and research institutions to support Ukrainian students and scientists are necessary. As a first priority, dedicated and unbureaucratic short‐term scholarship and grant programs are required to accommodate Ukrainian scientists; such programs have been already initiated by many organizations, for example, by EMBO, Volkswagen Stiftung, Max Planck Society, and the ERC among others. These help Ukrainian scientists to stay connected to research and become integrated into the European research landscape. In the long‐term and after the war, this aid should be complemented by funding for research centers of excellence in Ukraine, to which scientists could then return.Even though the priority must be to help Ukrainians, we must also think of students and colleagues in Russia who oppose the war and are affected by the sanctions. As the Iron Curtain closes again, we have to think differently about our ongoing and future collaborations. Although freezing most, if not all, research collaborations with official Russian organizations is justified, it would be a mistake to extend these sanctions to all scientists and students. There is already an exodus of Russian and Belarusian scholars, which will only accelerate in the next months and years, and accepting scientists who ask for political asylum will be beneficial for Europe.The fraction of Russian society in open opposition to the war is, unfortunately, smaller than that officially in support of it. At the beginning of the war, a number of Russian scientists published an open letter on the internet, in which they condemn this war (https://t‐invariant.org/2022/02/we‐are‐against‐war/). They clearly state that "The responsibility for unleashing a new war in Europe lies entirely with Russia. There is no rational justification for this war”, and “demand an immediate halt to all military operations directed against Ukraine". At the same time, other prominent Russian science and education officials signed the “Statement of the Russian Union of University Rectors (Provosts)”, which expressed unwavering support for Russia, its president and its Army and their goal to “to achieve demilitarization and denazification of Ukraine and thus to defend ourselves from the ever‐growing military threat” (https://www.rsr‐online.ru/news/2022‐god/obrashchenie‐rossiyskogo‐soyuza‐rektorov1/).Inevitably, Russian scientists must decide themselves how to live and continue their scientific work under the increasingly tight surveillance of the Kremlin regime. History is repeating itself. Not long ago, during the Cold War, Soviet scientists were largely isolated from the international research community and worked in government‐controlled research. In some fields, no one knew what they were working on or where. However, even in those dark times, courageous individuals such as Andrei Sakharov spoke out against the regime and tried to educate the next generation about the importance of free will. Many Soviet geneticists had been arrested under Stalin’s regime of terror and as a result of Lysenkoism and were executed or sent to the Gulag or had to emigrate, such as Nikolaj Timofeev‐Resovskij, one of the great geneticists of his time and an opponent of communism. As a result of sending dissident scientists to Siberia, great educational institutions were created in the region, which trained many famous scientists. History tells us that it is impossible to kill free will and the search for truth.The Russian invasion of Ukraine is a major humanitarian tragedy and a tragedy for science at many levels. Our hope is that the European science community, policymakers, and funders will be prepared to continue and expand support for our colleagues from Ukraine and eventually help to rebuild the bridges with Russian science that have been torn down.This commentary has been endorsed and signed by the EMBO Young Investigators and former Young Investigators listed below.

All signatories are current and former EMBO Young Investigators and endorse the statements in this article.
Igor AdameykoKarolinska Institut, Stockholm, Sweden
Bungo AkiyoshiUniversity of Oxford, United Kingdom
Leila AkkariNetherlands Cancer Institute, Amsterdam, Netherlands
Panagiotis AlexiouMasaryk University, Brno, Czech Republic
Hilary AsheFaculty of Life Sciences, University of Manchester, United Kingdom
Michalis AverofInstitut de Génomique Fonctionnelle de Lyon (IGFL), France
Katarzyna BandyraUniversity of Warsaw, Poland
Cyril BarinkaInstitute of Biotechnology AS CR, Prague, Czech Republic
Frédéric BergerGregor Mendel Institute of Molecular Plant Biology, Austrian Academy of Sciences, Vienna, Austria
Vitezslav BryjaInstitute of Experimental Biology, Masaryk University, Brno, Czech Republic
Janusz BujnickiInternational Institute of Molecular and Cell Biology, Warsaw, Poland
Björn BurmannUniversity Gothenburg, Sweden
Andrew CarterMRC Laboratory of Molecular Biology, Cambridge, United Kingdom
Pedro CarvalhoSir William Dunn School of Pathology University of Oxford, United Kingdom
Ayse Koca CaydasiKoç University, Istanbul, Turkey
Hsu‐Wen ChaoMedical University, Taipei, Taiwan
Jeffrey ChaoFriedrich Miescher Institute, Basel, Switzerland
Alan CheungUniversity of Bristol, United Kingdom
Tim ClausenResearch Institute for Molecular Pathology (IMP), Vienna, Austria
Maria Luisa CochellaThe Johns Hopkins University School of Medicine, USA
Francisco CubillosSantiago de Chile, University, Chile
Uri Ben‐DavidTel Aviv University, Tel Aviv, Israel
Sebastian DeindlUppsala University, Sweden
Pierre‐Marc DelauxLaboratoire de Recherche en Sciences Végétales, Castanet‐Tolosan, France
Christophe DessimozUniversity, Lausanne, Switzerland
Maria DominguezInstitute of Neuroscience, CSIC ‐ University Miguel Hernandez, Alicante, Spain
Anne DonaldsonInstitute of Medical Sciences, University of Aberdeen, United Kingdom
Peter DraberBIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
Xiaoqi FengJohn Innes Centre, Norwich, United Kingdom
Luisa FigueiredoInstitute of Molecular Medicine, Lisbon, Portugal
Reto GassmannInstitute for Molecular and Cell Biology, Porto, Portugal
Kinga Kamieniarz‐GdulaAdam Mickiewicz University in Poznań, Poland
Roger GeigerInstitute for Research in Biomedicine, Bellinzona, Switzerland
Niko GeldnerUniversity of Lausanne, Switzerland
Holger GerhardtMax Delbrück Center for Molecular Medicine, Berlin, Germany
Daniel Wolfram GerlichInstitute of Molecular Biotechnology (IMBA), Vienna, Austria
Jesus GilMRC Clinical Sciences Centre, Imperial College London, United Kingdom
Sebastian GlattMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland
Edgar GomesInstitute of Molecular Medicine, Lisbon, Portugal
Pierre GönczySwiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Maria GornaUniversity of Warsaw, Poland
Mina GoutiMax‐Delbrück‐Centrum, Berlin, Germany
Jerome GrosInstitut Pasteur, Paris, France
Anja GrothBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark
Annika GuseCentre for Organismal Studies, Heidelberg, Germany
Ricardo HenriquesInstituto Gulbenkian de Ciência, Oeiras, Portugal
Eva HoffmannCenter for Chromosome Stability, University of Copenhagen, Denmark
Thorsten HoppeCECAD at the Institute for Genetics, University of Cologne, Germany
Yen‐Ping HsuehAcademia Sinica, Taipei, Taiwan
Pablo HuertasAndalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Seville, Spain
Matteo IannaconeIRCCS San Raffaele Scientific Institute, Milan, Italy
Alvaro Rada‐IglesiasInstitue of Biomedicine and Biotechnology of Cantabria (IBBTEC)
University of Cantabria, Santander, Spain
Axel InnisInstitut Européen de Chimie et Biologie (IECB), Pessac, France
Nicola IovinoMPI für Immunbiologie und Epigenetik, Freiburg, Germany
Carsten JankeInstitut Curie, France
Ralf JansenInterfaculty Institute for Biochemistry, Eberhard‐Karls‐University Tübingen, Germany
Sebastian JessbergerHiFo / Brain Research Institute, University of Zurich, Switzerland
Martin JinekUniversity of Zurich, Switzerland
Simon Bekker‐JensenUniversity, Copenhagen, Denmark
Nicole JollerUniversity of Zurich, Switzerland
Luca JovineDepartment of Biosciences and Nutrition & Center for
Biosciences, Karolinska Institutet, Stockholm, Sweden
Jan Philipp JunkerMax‐Delbrück‐Centrum, Berlin, Germany
Anna KarnkowskaUniversity, Warsaw, Poland
Zuzana KeckesovaInstitute of Organic Chemistry and Biochemistry AS CR, Prague, Czech Republic
René KettingInstitute of Molecular Biology (IMB), Mainz, Germany
Bruno KlaholzInstitute of Genetics and Molecular and Cellular Biology (IGBMC), University of Strasbourg, Illkirch, France
Jürgen KnoblichInstitute of Molecular Biotechnology (IMBA), Vienna, Austria
Taco KooijCentre for Molecular Life Sciences, Nijmegen, Netherlands
Romain KoszulInstitut Pasteur, Paris, France
Claudine KraftInstitute for Biochemistry and Molecular Biology, Universität Freiburg, Germany
Alena KrejciFaculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic
Lumir KrejciNational Centre for Biomolecular Research (NCBR), Masaryk University, Brno, Czech Republic
Arnold KristjuhanInstitute of Molecular and Cell Biology, University of Tartu, Estonia
Yogesh KulathuMRC Protein Phosphorylation & Ubiquitylation Unit, University of Dundee, United Kingdom
Edmund KunjiMRC Mitochondrial Biology Unit, Cambridge, United Kingdom
Karim LabibMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, United Kingdom
Thomas LecuitDevelopmental Biology Institute of Marseilles ‐ Luminy (IBDML), France
Gaëlle LegubeCenter for Integrative Biology in Toulouse, Paul Sabatier University, France
Suewei LinAcademia Sinica, Taipei, Taiwan
Ming‐Jung LiuAcademia Sinica, Taipei, Taiwan
Malcolm LoganRandall Division of Cell and Molecular Biophysics, King’s College London, United Kingdom
Massimo LopesUniversity of Zurich, Switzerland
Jan LöweStructural Studies Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
Martijn LuijsterburgUniversity Medical Centre, Leiden, Netherlands
Taija MakinenUppsala University, Sweden
Sandrine Etienne‐MannevilleInstitut Pasteur, Paris, France
Miguel ManzanaresSpanish National Center for Cardiovascular Research (CNIC), Madrid, Spain
Jean‐Christophe MarineCenter for Biology of Disease, Laboratory for Molecular Cancer Biology, VIB & KU Leuven, Belgium
Sascha MartensMax F. Perutz Laboratories, University of Vienna, Austria
Elvira MassUniversität Bonn, Germany
Olivier MathieuClermont Université, Aubière, France
Ivan MaticMax Planck Institute for Biology of Ageing, Cologne, Germany
Joao MatosMax Perutz Laboratories, Vienna, Austria
Nicholas McGranahanUniversity College London, United Kingdom
Hind MedyoufGeorg‐Speyer‐Haus, Frankfurt, Germany
Patrick MeraldiUniversity of Geneva, Switzerland
Marco MilánICREA & Institute for Research in Biomedicine (IRB), Barcelona, Spain
Eric MiskaWellcome Trust/Cancer Research UK Gurdon Institute,
University of Cambridge, United Kingdom
Nuria MontserratInstitut de Bioenginyeria de Catalunya (IBEC), Barcelona, Spain
Nuno Barbosa‐MoraisInstitute of Molecular Medicine, Lisbon, Portugal
Antonin MorillonInstitut Curie, Paris, France
Rafal MostowyJagiellonian University, Krakow, Poland
Patrick MüllerUniversity of Konstanz, Konstanz, Germany
Miratul MuqitUniversity of Dundee, United Kigdom
Poul NissenCentre for Structural Biology, Aarhus University, Denmark
Ellen NollenEuropean Research Institute for the Biology of Ageing, University of Groningen, Netherlands
Marcin NowotnyInternational Institute of Molecular and Cell Biology, Warsaw, Poland
John O''NeillMRC Laboratory of Molecular Biology, Cambridge, United Kigdom
Tamer ÖnderKoc University School of Medicine, Istanbul, Turkey
Elin OrgUniversity of Tartu, Estonia
Nurhan ÖzlüKoç University, Istanbul, Turkey
Bjørn Panyella PedersenAarhus University, Denmark
Vladimir PenaLondon, The Institute of Cancer Research, United Kingdom
Camilo PerezBiozentrum, University of Basel, Switzerland
Antoine PetersFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland
Clemens PlaschkaIMP, Vienna, Austria
Pavel PlevkaCEITEC, Masaryk University, Brno, Czech Republic
Hendrik PoeckTechnische Universität, München, , Germany
Sophie PoloUniversité Diderot (Paris 7), Paris, France
Simona PoloIFOM ‐ The FIRC Institute of Molecular Oncology, Milan, Italy
Magdalini PolymenidouUniversity of Zurich, Switzerland
Freddy RadtkeSwiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Markus RalserInstitute of Biochemistry Charité, Berlin, Germany & MRC National Institute for Medical Research, London, United Kingdom
Jan RehwinkelJohn Radcliffe Hospital, Oxford, United Kingdom
Maria RescignoEuropean Institute of Oncology (IEO), Milan, Italy
Katerina RohlenovaPrague, Institute of Biotechnology, Czech Republic
Guadalupe SabioCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Ana Jesus Garcia SaezUniversity of Cologne, CECAD Research Center, Germany
Iris SaleckerInstitut de Biologie de l''Ecole Normale Supérieure (IBENS), Paris, France
Peter SarkiesUniversity of Oxford, United Kingdom
Frédéric SaudouGrenoble Institute of Neuroscience, France
Timothy SaundersCentre for Mechanochemical Cell Biology, Interdisciplinary Biomedical Research Building, Warwick Medical School, Coventry, United Kingdom
Orlando D. SchärerIBS Center for Genomic Integrity, Ulsan, South Korea
Arp SchnittgerBiozentrum Klein Flottbek, University of Hamburg, Germnay
Frank SchnorrerAix Marseille University, CNRS, IBDM, Turing Centre for Living Systems, Marseille, France
Maya SchuldinerDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
Schraga SchwartzWeizmann Institute of Science, Rehovot, Israel
Martin SchwarzerInstitute of Microbiology, Academy of Sciences of the Czech Republic
Claus MariaInstituto de Medicina Molecular Faculdade de Medicina da Universidade de Lisboa, Portugal
Hayley SharpeThe Babraham Institute, United Kingdom
Halyna ShcherbataInstitute of Cell Biochemistry, Hannover Medical School, Hannover, Germany
Eric SoDepartment of Haematological Medicine, King''s College London, United Kingdom
Victor SourjikMax Planck Institute for Terrestrial Microbiology, Marburg, Germany
Anne SpangBiozentrum, University of Basel, Switzerland
Irina StanchevaInstitute of Cell Biology, University of Edinburgh, United Kingdom
Bas van SteenselDepartment of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, Netherlands
Richard SteflCEITEC, Masaryk University, Brno, Czech Republic
Yonatan StelzerWeizmann Institute of Science, Rehovot, Israel
Julian StingeleLudwig‐Maximilians‐Universität, München, Germany
Katja SträßerInstitute for Biochemistry, University of Giessen, Germany
Kvido StrisovskyInstitute of Organic Chemistry and Biochemistry ASCR, Prague, Czech Republic
Joanna SulkowskaUniversity, Warsaw, Poland
Grzegorz SumaraNencki Institute of Experimental Biology, Warsaw, Poland
Karolina SzczepanowskaInternational Institute Molecular Mechanisms & Machines PAS, Warsaw, Poland
Luca TamagnoneInstitute for Cancer Research and Treatment, University of Torino Medical School, Italy
Meng How TanSingapore, Nanyang Technological University, Singapore
Nicolas TaponCancer Research UK London Research Institute, United Kingdom
Nicholas M. I. TaylorUniversity, Copenhagen, Denmark
Sven Van TeeffelenUniversité de Montréal, Canada
Maria Teresa TeixeiraLaboratory of Molecular and Cellular Biology of Eukaryotes, IBPC, Paris, France
Aurelio TelemanGerman Cancer Research Center (DKFZ), Heidelberg, Germany
Pascal TherondInstitute Valrose Biology, University of Nice‐Sophia Antipolis, France
Pavel TolarUniversity College London, United Kingdom
Isheng Jason TsaiAcademia Sinica, Taipei, Taiwan
Helle UlrichInstitute of Molecular Biology (IMB), Mainz, Germany
Stepanka VanacovaCentral European Institute of Technology, Masaryk University, Brno, Czech Republic
Henrique Veiga‐FernandesChampalimaud Center for the Unknown, Lisboa, Portugal
Marc VeldhoenInstituto de Medicina Molecular, Lisbon, Portugal
Louis VermeulenAcademic Medical Centre, Amsterdam, Netherlands
Uwe VinkemeierUniversity of Nottingham Medical School, United Kingdom
Helen WaldenMRC Protein Phosphorylation & Ubiquitylation Unit, University of Dundee, United Kingdom
Michal WandelInstitute of Biochemistry and Biophysics, PAS, Warsaw, Poland
Julie WelburnWellcome Trust Centre, Edinburgh, United Kingdom
Ervin WelkerInstitute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary
Gerhard WingenderIzmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey
Thomas WollertInstitute Pasteur, Membrane Biochemistry and Transport, Centre François Jacob, Paris, France
Hyun YoukUniversity of Massachusetts Medical School, USA
Christoph ZechnerMPI für molekulare Zellbiologie und Genetik, Dresden, Germany
Philip ZegermanWellcome Trust / Cancer Research UK Gurdon Institute, University of Cambridge, United Kingdom
Alena ZikováInstitute of Parasitology, Biology Centre AS CR, Ceske Budejovice, Czech Republic
Piotr ZiolkowskiAdam Mickiewicz University, Poznan, Poland
David ZwickerMPI für Dynamik und Selbstorganisation, Göttingen, Germany
Open in a separate window  相似文献   

3.
The Norway spruce genome provides key insights into the evolution of plant genomes, leading to testable new hypotheses about conifer, gymnosperm, and vascular plant evolution.In the past year a burst of plant genome sequences have been published, providing enhanced phylogenetic coverage of green plants (Figure (Figure1)1) and inclusion of new agricultural, ecological, and evolutionary models. Collectively, these sequences are revealing some extraordinary structural and evolutionary attributes in plant genomes. Perhaps most surprising is the exceptionally high frequency of whole-genome duplication (WGD): nearly every genome that has been analyzed has borne the signature of one or more WGDs, with particularly notable events having occurred in the common ancestors of seed plants, of angiosperms, and of core eudicots (the latter ''WGD'' represents two WGDs in close succession) [1,2]. Given this tendency for plant genomes to duplicate and then return to an essentially diploid genetic system (an example is the cotton genomes, which have accumulated the effects of perhaps 15 WGDs [3]), the conservation of genomes in terms of gene number, chromosomal organization, and gene content is astonishing. From the publication of the first plant genome, Arabidopsis thaliana [4], the number of inferred genes has been between 25,000 and 30,000, with many gene families shared across all land plants, although the number of members and patterns of expansion and contraction vary. Furthermore, conserved synteny has been detected across the genomes of diverse angiosperms, despite WGDs, diploidization, and millions of years of evolution.Open in a separate windowFigure 1Simplified phylogeny of land plants, showing major clades and their component lineages. Asterisks indicate species (or lineage) for which whole-genome sequence (or sequences) is (are) available. Increases and decreases in genome size are shown by arrows.Despite the proliferation of genome sequences available for angiosperms, genome-level data for both ferns (and their relatives, collectively termed monilophytes; Figure Figure1)1) and gymnosperms have been conspicuously lacking - until recently, with the publication of the genome sequence of the gymnosperm Norway spruce (Picea abies) [5]. The large genome sizes for both monilophytes and gymnosperms have discouraged attempts at genome sequencing and assembly, whereas the smaller genome size of angiosperms has resulted in more genome sequences being available (Table (Table1)1) [6]. Because of this limited phylogenetic sample, our understanding of the timing and phylogenetic positions of WGDs, the core number of plant genes, possible conserved syntenic regions, and patterns of expansion and contraction of gene families across both tracheophytes (vascular plants) and across all land plants is imperfect. This sampling problem is particularly acute in analyses of the genes and genomes of seed plants; many hundreds of genes are present in angiosperms that are not present in mosses or lycophytes, but whether these genes arose in the common ancestor of seed plants or of angiosperms cannot be determined without a gymnosperm genome sequence. The Norway spruce genome therefore offers tremendous power, not only for understanding the structure and evolution of conifer genomes, but also as a reference for interpreting gene and genome evolution in angiosperms.

Table 1

Genome sizes in land plants
LineageRange (1C; pg)Mean
Gymnosperms
  Conifers
    Pinaceae9.5-36.023.7
    Cupressaceae8.3-32.112.8
    Sciadopitys 20.8n/a
  Gnetales
    Ephedraceae8.9-15.78.9
    Gnetaceae2.3-4.02.3
    Cycadaceae12.6-14.813.4
    Ginkgo biloba11.75n/a
Monilophytes
    Ophioglossaceae10.2-65.631.05
    Equisetaceae12.9-30422.0
    Psilotum72.7n/a
  Leptosporangiate ferns
    Polypodiaceae7.5-19.77.5
    Aspleniaceae4.1-9.16.2
    Athyriaceae6.3-9.37.6
    Dryopteridaceae6.8-23.611.7
  Water ferns
    Azolla0.77n/a
Angiosperms
    Oryza sativa 0.50n/a
    Amborella trichopoda0.89n/a
    Arabidopsis thaliana0.16n/a
    Zea mays2.73n/a
Open in a separate windown/a, not applicable. Data based on [6].  相似文献   

4.

Background

Globally, the status of women’s health falls short of its potential. In addition to the deleterious ethical and human rights implications of this deficit, the negative economic impact may also be consequential, but these mechanisms are poorly understood. Building on the literature that highlights health as a driver of economic growth and poverty alleviation, we aim to systematically investigate the broader economic benefits of investing in women’s health.

Methods

Using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, we systematically reviewed health, gender, and economic literature to identify studies that investigate the impact of women’s health on micro- and macroeconomic outcomes. We developed an extensive search algorithm and conducted searches using 10 unique databases spanning the timeframe 01/01/1970 to 01/04/2013. Articles were included if they reported on economic impacts stemming from changes in women’s health (table of outcome measures included in full review,
Outcome measures   
FertilityIntergenerational Health SpilloverEducationProductivitySavings
Microeconomic level    
Total fertility rateChild survivalEnrollment in schoolIncomeMoney
Change in fertilityChild wellbeing and behaviorYears of schoolingPurchasing powerAssets
Age at first birth/ teenage pregnanciesAnthropometryEarly drop outPerformance
Birth spacingImproved cognitive developmentPerformance in school
 Life expectancyHigher education 
 Adult health outcomesLiteracy 
 Nutrition  
 Intrauterine growth  
Macroeconomic level    
Open in a separate windowGross domestic product/gross national product, gross domestic product/gross national product growth, income per capita, labor force participation, per capita income.

Results

The existing literature indicates that healthier women and their children contribute to more productive and better-educated societies. This study documents an extensive literature confirming that women’s health is tied to long-term productivity: the development and economic performance of nations depends, in part, upon how each country protects and promotes the health of women. Providing opportunities for deliberate family planning; healthy mothers before, during, and after childbirth, and the health and productivity of subsequent generations can catalyze a cycle of positive societal development.

Conclusions

This review highlights the untapped potential of initiatives that aim to address women’s health. Societies that prioritize women’s health will likely have better population health overall, and will remain more productive for generations to come.  相似文献   

5.
Does an Eye-Hand Coordination Test Have Added Value as Part of Talent Identification in Table Tennis? A Validity and Reproducibility Study     
Irene R. Faber  Frits G. J. Oosterveld  Maria W. G. Nijhuis-Van der Sanden 《PloS one》2014,9(1)
This study investigated the added value, i.e. discriminative and concurrent validity and reproducibility, of an eye-hand coordination test relevant to table tennis as part of talent identification. Forty-three table tennis players (7–12 years) from national (n = 13), regional (n = 11) and local training centres (n = 19) participated. During the eye-hand coordination test, children needed to throw a ball against a vertical positioned table tennis table with one hand and to catch the ball correctly with the other hand as frequently as possible in 30 seconds. Four different test versions were assessed varying the distance to the TotalNationalRegionalLocalTotal43131119Boys268810Girls17539Age (years)10.4±1.410.9±1.510.4±1.510.1±1.47 year olds1--18 year olds51139 year olds3-3-10 year olds1232711 year olds1151512 year olds11443Length (cm)149±11150±12150±12148±10Weight (kg )38±837±737±738±9Right-handed359917Left-handed8422Training (hours*week-1)6 (0–20)11 (7–20)7 (4–11)2 (0–3)Competition (points)173 (−52–430)297 (144–430)188 (72–317)36 (−52–130)Open in a separate windowData are frequencies, except for age, length and weight (years±SD), and training and competition (mean (range)).  相似文献   

6.
Vasoconstricción cerebral fatal,presentación inusual de una enfermedad inusual     
Hernn Bayona  María Camila Valencia  Anglica Pea  Natalia Ramírez  Carlos Martínez 《Biomédica : revista del Instituto Nacional de Salud》2021,41(2):225
The reversible cerebral vasoconstriction syndrome is a variable, segmental, and multifocal constriction of brain arteries, usually with a benign course.We describe the case of a 49-year-old woman who presented with headaches, visual symptoms, and seizures. Three days after admission, vasoconstriction areas were found in at least two vascular territories in two segments of the same arteries.The patient was admitted to the intensive care unit where her blood pressure was monitored and she received medical treatment. Surprisingly, the patient presented an unpredicted evolution in developing malignant cerebral edema on the seventh day after admission. She then suffered brain death and was taken to organ donation. A guided nervous system necropsy was later performed. The pathology discarded vasculitis and exhibited hemorrhage areas in the cerebral convexity.Herein, we discuss the most relevant aspects of cases with fulminant evolution reported in the literature. The reversible cerebral vasoconstriction syndrome is usually associated with fatal outcomes when patients exhibit focalization, their first neuroimaging typically shows disturbances, and a rapid clinical deterioration occurs. It is crucial to identify factors linked to poor prognosis and set intervention strategies and early prevention.Key words: stroke, brain hemorrhage, vasoconstriction, mortality, prognosis

El síndrome de vasoconstricción cerebral reversible se produce por una vasoconstricción variable, segmentaria y multifocal, de las arterias cerebrales (1).Esta condición patológica es más común en mujeres entre los 10 y los 76 años, con un pico a los 42 años (2). Hasta en el 70% de los pacientes puede haber factores precipitantes (3), entre los cuales se han mencionado estrés emocional y físico, actividad sexual, puerperio, trauma, maniobra de Valsalva, y uso de sustancias vasoactivas o de inhibidores selectivos de la recaptación de serotonina (4-6).Los hallazgos clínicos son diversos, pero se sabe que la forma más común de presentación clínica es la cefalea “en trueno” (7). La principal herramienta diagnóstica es la angiografía cerebral, considerada la prueba de referencia, aunque no es el único estudio de imagenología que se puede utilizar como método de evaluación (3,8).A pesar de que muchos casos se resuelven de forma espontánea, algunos pacientes pueden desarrollar complicaciones como hemorragia, convulsiones e infartos cerebrales (3), e incluso, se han reportado casos fatales asociados con este síndrome (9-12).Se presenta el caso de una paciente que falleció. Se describe la secuencia de eventos clínicos que llevaron a su muerte, haciendo énfasis en aquellos factores que deben alertar sobre un posible curso fulminante.  相似文献   

7.
Mortalidad causada por animales venenosos en Venezuela (2000-2009): nuevo patrón epidemiológico     
Leonardo De Sousa  Adolfo Borges  Enzo De Sousa-Insana  Aleikar Vsquez-Surez 《Biomédica : revista del Instituto Nacional de Salud》2021,41(1):29
IntroducciónLos accidentes causados por animales venenosos ocurren con mucha frecuencia en comunidades pobres con acceso limitado a los servicios de salud. Se les consideran enfermedades desatendidas y son una de las causas importantes de morbimortalidad en varias naciones del mundo, incluida Venezuela.ObjetivoEvaluar la mortalidad por contacto traumático con animales venenosos (serie X20-X29) en Venezuela en el periodo de 2000 a 2009.Materiales y métodosLos datos se obtuvieron de los anuarios de mortalidad del Ministerio de Salud.ResultadosSe registraron 759 decesos, la mayoría de ellos en el 2009. La primera causa fue la mordedura de serpientes (n=323; 42,6%), seguida por la picadura de himenópteros (n=170; 22,4%), la mordedura de centípedos (n=106; 14,0%) y la picadura de escorpiones (n=76; 10,0%). La mediana de la tasa de mortalidad general para el periodo fue de 0,285 fallecidos por 100.000 habitantes, en tanto que, por grupo específico, fue de 0,120 para ofidios, de 0,065 para himenópteros, de 0,035 para centípedos y de 0,025 para escorpiones.ConclusiónAl comparar estos datos con los antecedentes históricos, se evidenció la modificación del patrón de mortalidad en el país caracterizada por un aumento significativo de los decesos por centípedos, tercera causa de muerte, lo que reubica la picadura de escorpiones como la cuarta causa de mortalidad.Palabras clave: serpientes, himenópteros, escorpiones, mortalidad, epidemiología  相似文献   

8.
Detección de errores de medicación mediante un programa de seguimiento y minimización en pacientes ambulatorios de Colombia, 2018-2019     
Manuel Enrique Machado-Duque  Jorge Enrique Machado-Alba  Andrs Gaviria-Mendoza  Luis Fernando Valladales-Restrepo  Ilsa Yadira Parrado-Fajardo  Mauren Ospina-Castellanos  Luisa Fernanda Rojas-Chavarro  John Alexander Lpez-Rincn 《Biomédica : revista del Instituto Nacional de Salud》2021,41(1):79
  相似文献   

9.
Inserción “velamentosa”, encefalopatía hipóxico-isquémica y rehabilitación neurológica: reporte de caso     
María Jos Úsuga  Gloria Alejandra Jaramillo  Valentina Palacio  Sergio Andrs Correa  Juan Camilo Surez-Escudero 《Biomédica : revista del Instituto Nacional de Salud》2021,41(1):8
La encefalopatía hipóxico-isquémica es una causa frecuente e importante de daño neurológico en recién nacidos a término y prematuros. Un evento centinela de esta condición es la vasa previa, específicamente cuando existe anormalidad de la placenta como la inserción “velamentosa” del cordón umbilical. Algunos reportes evidencian la asociación entre estas dos condiciones, pero son escasos los que dan cuenta del proceso de recuperación y del pronóstico neurológico de los niños afectados por ellas.Se presenta el caso de un paciente, con antecedentes de inserción “velamentosa” del cordón umbilical y encefalopatía hipóxico-isquémica, que recibió hipotermia terapéutica (cool cap). Se describe su proceso de rehabilitación neurológica y se calculó el porcentaje de probabilidad de presentar esta condición frente a la población sin estos factores. El niño tenía cinco años y el puntaje en su prueba de Apgar fue de 0 al minuto y de 2 a los 15 minutos. Desarrolló encefalopatía hipóxico-isquémica grave secundaria a una inserción “velamentosa” del cordón umbilical sin diagnóstico prenatal, con gran compromiso neurológico y multisistémico inicial. El proceso de recuperación incluyó el manejo inicial multidisciplinario en la unidad de cuidados intensivos neonatales y el inicio temprano de habilitación neurológica.Hoy el niño está escolarizado y en terapia integral, no presenta deficiencias motoras ni sensoriales en el examen físico, aunque la prueba neuropsicológica sugiere un riesgo de trastorno por déficit de atención e hiperactividad. Habitualmente, los niños con encefalopatía hipóxico-isquémica grave presentan discapacidad por deficiencias motoras, cognitivas o conductuales. El haber recibido hipotermia terapéutica y un manejo estructurado de rehabilitación redujo en gran medida las deficiencias esperadas y ha promovido un satisfactorio desarrollo físico y neurológico.Palabras clave: cordón umbilical, hipoxia-isquemia encefálica, hipotermia inducida, rehabilitación neurológica  相似文献   

10.
Perioperative Opioid Counseling Reduces Opioid Use Following Primary Total Joint Arthroplasty     
Christopher N. Carender  Christopher A. Anthony  Edward O. Rojas  Nicolas O. Noiseux  Nicholas A. Bedard  Timothy S. Brown 《The Iowa orthopaedic journal》2022,42(1):169
BackgroundPreoperative counseling may reduce postoperative opioid requirements; however, there is a paucity of randomized controlled trials (RCTs) demonstrating efficacy. The purpose of this study was to perform an interventional, telehealth-based RCT evaluating the effect of peri-operative counseling on quantity and duration of opioid consumption following primary total joint arthroplasty (TJA).MethodsParticipants were randomized into three groups: 1. Control group, no perioperative counseling; 2. Intervention group, preoperative educational video; 3. Intervention group, preoperative educational video and postoperative acceptance and commitment therapy (ACT). Opioid consumption was evaluated daily for 14 days and at 6 weeks postoperatively. Best-case and worse-case intention to treat analyses were performed to account for non-responses. Bonferroni corrections were applied.Results183 participants were analyzed (63 in Group 1, 55 in Group 2, and 65 in Group 3). At 2 weeks postoperatively, there was no difference in opioid consumption between Groups 1, 2, and 3 (p>0.05 for all). At 6 weeks postoperatively, Groups 2 and 3 had consumed significantly less opioids than Group 1 (p=0.04, p<0.001) (VariableGroupp-value1. Control2. Video OnlyVideo + ACTSex (n, % female)39 (62%)32 (58%)40 (62%)0.90Surgery (n, % THA)26 (41%)21 (38%)31 (47%)0.56Age (mean ± SD; years)59 ± 1159 ± 1158 ± 9Overall: 0.83
1v2: 0.98
2v3: 0.65
2v3: 0.56Prolonged Opioid Use > 60 mo. (n, %)000-Opioid Use Within 3 mo. of Index Surgery (n, %)0 (14%)4 (7%)5 (8%)0.34
Open in a separate windowSD – standard deviation.Table 2.Quantity of Opioid Consumption at 2 Weeks Postoperatively, Best-Case Scenario
ValueGroupp-valuep-value (corrected)
1. Control2. Video OnlyVideo + ACT
Median192113901v2: 0.281v2: 0.56
IQR60-3088-30815-2481v3: 0.04*1v3: 0.15
Min0002v3: 0.472v3: 0.56
Max690623694
Open in a separate windowMedian, interquartile range (IQR), minimum (min), and maximum (max) values are reported in morphine milliequivalents (MME). * denotes statistical significance.ConclusionPerioperative opioid counseling significantly decreases the quantity and duration of opioid consumption at 6 weeks following primary TJA. Level of Evidence: I  相似文献   

11.
BANK1 and BLK Act through Phospholipase C Gamma 2 in B-Cell Signaling     
Manuel Bernal-Quirós  Ying-Yu Wu  Marta E. Alarcón-Riquelme  Casimiro Castillejo-López 《PloS one》2013,8(3)
  相似文献   

12.
High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses     
Cássio Pontes Octaviani  Makoto Ozawa  Shinya Yamada  Hideo Goto  Yoshihiro Kawaoka 《Journal of virology》2010,84(20):10918-10922
  相似文献   

13.
Widespread Distribution of Cell Defense against d-Aminoacyl-tRNAs     
Sandra Wydau  Guillaume van der Rest  Caroline Aubard  Pierre Plateau    Sylvain Blanquet 《The Journal of biological chemistry》2009,284(21):14096-14104
Several l-aminoacyl-tRNA synthetases can transfer a d-amino acid onto their cognate tRNA(s). This harmful reaction is counteracted by the enzyme d-aminoacyl-tRNA deacylase. Two distinct deacylases were already identified in bacteria (DTD1) and in archaea (DTD2), respectively. Evidence was given that DTD1 homologs also exist in nearly all eukaryotes, whereas DTD2 homologs occur in plants. On the other hand, several bacteria, including most cyanobacteria, lack genes encoding a DTD1 homolog. Here we show that Synechocystis sp. PCC6803 produces a third type of deacylase (DTD3). Inactivation of the corresponding gene (dtd3) renders the growth of Synechocystis sp. hypersensitive to the presence of d-tyrosine. Based on the available genomes, DTD3-like proteins are predicted to occur in all cyanobacteria. Moreover, one or several dtd3-like genes can be recognized in all cellular types, arguing in favor of the nearubiquity of an enzymatic function involved in the defense of translational systems against invasion by d-amino acids.Although they are detected in various living organisms (reviewed in Ref. 1), d-amino acids are thought not to be incorporated into proteins, because of the stereospecificity of aminoacyl-tRNA synthetases and of the translational machinery, including EF-Tu and the ribosome (2). However, the discrimination between l- and d-amino acids by aminoacyl-tRNA synthetases is not equal to 100%. Significant d-aminoacylation of their cognate tRNAs by Escherichia coli tyrosyl-, tryptophanyl-, aspartyl-, lysyl-, and histidyl-tRNA synthetases has been characterized in vitro (39). Recently, using a bacterium, transfer of d-tyrosine onto tRNATyr was shown to occur in vivo (10).With such misacylation reactions, the resulting d-aminoacyl-tRNAs form a pool of metabolically inactive molecules, at best. At worst, d-aminoacylated tRNAs infiltrate the protein synthesis machinery. Although the latter harmful possibility has not yet been firmly established, several cells were shown to possess a d-tyrosyl-tRNA deacylase, or DTD, that should help them counteract the accumulation of d-aminoacyl-tRNAs. This enzyme shows a broad specificity, being able to remove various d-aminoacyl moieties from the 3′-end of a tRNA (46, 11). Such a function makes the deacylase a member of the family of enzymes capable of editing in trans mis-aminoacylated tRNAs. This family includes several homologs of aminoacyl-tRNA synthetase editing domains (12), as well as peptidyl-tRNA hydrolase (13, 14).Two distinct deacylases have already been discovered. The first one, called DTD1, is predicted to occur in most bacteria and eukaryotes (see d-amino acids, including d-tyrosine (6). In fact, in an E. coli Δdtd strain grown in the presence of 2.4 mm d-tyrosine, as much as 40% of the cellular tRNATyr pool becomes esterified with d-tyrosine (10).

TABLE 1

Distribution of DTD1 and DTD2 homologs in various phylogenetic groupsHomologs of DTD1 and DTD2 were searched for using a genomic Blast analysis against complete genomes in the NCBI Database (www.ncbi.nlm.nih.gov). Values in the table are number of species. For instance, E. coli is counted only once in γ-proteobacteria despite the fact that several E. coli strains have been sequenced.
DTD1DTD2DTD1 + DTD2None
Bacteria
    Acidobacteria 2 0 0 0
    Actinobacteria 27 0 0 8
    Aquificae 1 0 0 0
    Bacteroidetes/Chlorobi 12 0 0 5
    Chlamydiae 1 0 0 6
    Chloroflexi 4 0 0 0
    Cyanobacteria 5 0 0 16
    Deinococcus/Thermus 4 0 0 0
    Firmicutes
        Bacillales 19 0 0 0
        Clostridia 19 0 0 0
        Lactobacillales 23 0 0 0
        Mollicutes 0 0 0 15
    Fusobacteria/Planctomycetes 2 0 0 0
    Proteobacteria
        α 6 0 0 55
        β 24 0 0 11
        γ 80 0 0 8
        δ 15 0 0 0
        ε 1 0 0 12
    Spirochaetes 0 0 0 7
    Thermotogae 5 0 0 0
Archaea
    Crenarchaeota 0 13 0 0
    Euryarchaeota 1 26 0 2
    Nanoarchaeota 0 0 0 1
Eukaryota
    Dictyosteliida 1 0 0 0
    Fungi/Metazoa
        Fungi 13 0 0 1
        Metazoa 19 0 0 0
    Kinetoplastida 3 0 0 0
    Viridiplantae 4 4 4 0
Open in a separate windowHomologs of dtd/DTD1 are not found in the available archaeal genomes except that of Methanosphaera stadtmanae. A search for deacylase activity in Sulfolobus solfataricus and Pyrococcus abyssi led to the detection of another enzyme (DTD2), completely different from the DTD1 protein (15). Importing dtd2 into E. coli functionally compensates for dtd deprivation. As shown in 16).Several cells contain neither dtd nor dtd2 homologs (d-tyrosyl-tRNA deacylase (DTD3). This protein, encoded by dtd3, behaves as a metalloenzyme. Sensitivity of the growth of Synechocystis to external d-tyrosine is strongly exacerbated by the disruption of dtd3. Moreover, expression of the Synechocystis DTD3 in a Δdtd E. coli strain, from a plasmid, restores the resistance of the bacterium to d-tyrosine. Finally, using the available genomes, we examined the occurrence of DTD3 in the living world. The prevalence of DTD3-like proteins is surprisingly high. It suggests that the defense of protein synthesis against d-amino acids is universal.  相似文献   

14.
Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes     
Dzana Sudic Hukic  Louise Frisén  Lena Backlund  Catharina Lavebratt  Mikael Landén  Lil Tr?skman-Bendz  Gunnar Edman  Martin Schalling  Urban ?sby 《PloS one》2013,8(7)

Introduction

Bipolar disorder is characterized by severe mood symptoms including major depressive and manic episodes. During manic episodes, many patients show cognitive dysfunction. Dopamine and glutamate are important for cognitive processing, thus the COMT and DAOA genes that modulate the expression of these neurotransmitters are of interest for studies of cognitive function.

Methodology

Focusing on the most severe episode of mania, a factor was found with the combined symptoms of talkativeness, distractibility, and thought disorder, considered a cognitive manic symptoms (CMS) factor. 488 patients were genotyped, out of which 373 (76%) had talkativeness, 269 (55%) distractibility, and 372 (76%) thought disorder. 215 (44%) patients were positive for all three symptoms, thus showing CMS (Bipolar disorder type 1 [n]488Men [n (%)]209 (43)Talkativeness [n (%)]373 (76)Distracibility [n (%)]269 (55)Thought disorder [n (%)]372 (76)Cognitive manic symptoms* [n (%)]215 (44)Men [n (%)]81 (39)Non-Cognitive manic symptoms [n (%)]248 (51)Men [n (%)]117 (56)Unknown [n (%)]25 (5)Men [n (%)]11 (44)Anonymous blood donors (ABD)1044Men [n (%)]616 (59)Open in a separate window*having all three symptoms: talkativeness, distractibility, and tought disorder.

Results

The finding of this study was that cognitive manic symptoms in patients with bipolar 1 disorder was associated with genetic variants in the DAOA and COMT genes. Nominal association for DAOA SNPs and COMT SNPs to cognitive symptoms factor in bipolar 1 disorder was found in both allelic (BP1 CMSBP1 non-CMSABDBP1 CMS vs. non-CMSb BP1 CMS vs. ABD controlsb GeneSNPa aa/ab/bbaa/ab/bbaa/ab/bbpEMP1c EMP2d OR [95% CI] e pEMP1c EMP2d OR [95% CI] e DAOA rs3916967 (C/T)32/88/8950/118/77177/494/3610.0180.0180.210.72 [0.55–0.93]0.0290.0260.280.78 [0.66–1.0] DAOA rs2391191 (A/C)28/75/7939/111/70179/487/3570.0550.0390.500.75 [0.57–1.0]0.0200.0190.210.75 [0.63–1.0] DAOA rs1935062 (C/A)26/67/8935/102/86146/460/4050.120.120.780.80 [0.58–1.0]0.0690.0660.520.80 [0.65–1.0] COMT rs5993883 (T/G)33/120/5371/112/57269/510/2230.0250.0300.270.73 [0.56–0.95]0.0017* 1.0E−4 * 0.021* 0.68 [0.91–1.4] COMT rs165599 (G/A)29/94/8725/93/12687/443/5010.0930.0940.691.27 [1.0–1.8]0.0140.0170.161.34 [1.1–1.7]Open in a separate windowaSNP (minor allele(a)/major allele(b)).bgender and rs1718119 as covariate.cpoint-wise p-value from 10,000 pemutations with no covarite (EMP1).dcorrected empirical p-value by max (T) permutation.eodds ratio (OR), the proportion of minor versus major allele affected (cognitive manic symptoms factor)/proportion of minor versus major allele unaffected (non-cognitive manic symptoms factor or ABD controls).*significant after correction for multiple testing by max (T) permutation.

Table 3

Haplotype association of haplotype group 1 in bipolar 1 patients with cognitive manic symptoms (CMS) compared with non-CMS patients or ABD controls in the DAOA gene.
CMS vs non-CMSb CMS vs ABDb
DAOA rs3916967rs2391191rs1935062Fa pOR [95% CI]c Fa pOR [95% CI]c
Haplotype 1CAC0.320.250.83 [0.66–1.1]0.330.140.83 [0.71–1.1]
Haplotype 2TGC0.0320.340.64 [0.32–1.1]0.0370.190.58 [0.37–1.1]
Haplotype 3CAA0.0740.0770.58 [0.39–0.89]0.0750.100.65 [0.47–1.0]
Haplotype 4TGA0.570.0291.38 [1.17–1.8]0.560.00571.41 [1.1–1.6]
Open in a separate windowafrequency (F) in sample.bgender and rs1718119 as covariates.codds ratios (OR) for each haplotype.

Conclusion

Identifying genes associated with cognitive functioning has clinical implications for assessment of prognosis and progression. Our finding are consistent with other studies showing genetic associations between the COMT and DAOA genes and impaired cognition both in psychiatric disorders and in the general population.  相似文献   

15.
Antimicrobial Activity of Simulated Solar Disinfection against Bacterial,Fungal, and Protozoan Pathogens and Its Enhancement by Riboflavin     
Wayne Heaselgrave  Simon Kilvington 《Applied and environmental microbiology》2010,76(17):6010-6012
Riboflavin significantly enhanced the efficacy of simulated solar disinfection (SODIS) at 150 watts per square meter (W m−2) against a variety of microorganisms, including Escherichia coli, Fusarium solani, Candida albicans, and Acanthamoeba polyphaga trophozoites (>3 to 4 log10 after 2 to 6 h; P < 0.001). With A. polyphaga cysts, the kill (3.5 log10 after 6 h) was obtained only in the presence of riboflavin and 250 W m−2 irradiance.Solar disinfection (SODIS) is an established and proven technique for the generation of safer drinking water (11). Water is collected into transparent plastic polyethylene terephthalate (PET) bottles and placed in direct sunlight for 6 to 8 h prior to consumption (14). The application of SODIS has been shown to be a simple and cost-effective method for reducing the incidence of gastrointestinal infection in communities where potable water is not available (2-4). Under laboratory conditions using simulated sunlight, SODIS has been shown to inactivate pathogenic bacteria, fungi, viruses, and protozoa (6, 12, 15). Although SODIS is not fully understood, it is believed to achieve microbial killing through a combination of DNA-damaging effects of ultraviolet (UV) radiation and thermal inactivation from solar heating (21).The combination of UVA radiation and riboflavin (vitamin B2) has recently been reported to have therapeutic application in the treatment of bacterial and fungal ocular pathogens (13, 17) and has also been proposed as a method for decontaminating donor blood products prior to transfusion (1). In the present study, we report that the addition of riboflavin significantly enhances the disinfectant efficacy of simulated SODIS against bacterial, fungal, and protozoan pathogens.Chemicals and media were obtained from Sigma (Dorset, United Kingdom), Oxoid (Basingstoke, United Kingdom), and BD (Oxford, United Kingdom). Pseudomonas aeruginosa (ATCC 9027), Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633), Candida albicans (ATCC 10231), and Fusarium solani (ATCC 36031) were obtained from ATCC (through LGC Standards, United Kingdom). Escherichia coli (JM101) was obtained in house, and the Legionella pneumophila strain used was a recent environmental isolate.B. subtilis spores were produced from culture on a previously published defined sporulation medium (19). L. pneumophila was grown on buffered charcoal-yeast extract agar (5). All other bacteria were cultured on tryptone soy agar, and C. albicans was cultured on Sabouraud dextrose agar as described previously (9). Fusarium solani was cultured on potato dextrose agar, and conidia were prepared as reported previously (7). Acanthamoeba polyphaga (Ros) was isolated from an unpublished keratitis case at Moorfields Eye Hospital, London, United Kingdom, in 1991. Trophozoites were maintained and cysts prepared as described previously (8, 18).Assays were conducted in transparent 12-well tissue culture microtiter plates with UV-transparent lids (Helena Biosciences, United Kingdom). Test organisms (1 × 106/ml) were suspended in 3 ml of one-quarter-strength Ringer''s solution or natural freshwater (as pretreated water from a reservoir in United Kingdom) with or without riboflavin (250 μM). The plates were exposed to simulated sunlight at an optical output irradiance of 150 watts per square meter (W m−2) delivered from an HPR125 W quartz mercury arc lamp (Philips, Guildford, United Kingdom). Optical irradiances were measured using a calibrated broadband optical power meter (Melles Griot, Netherlands). Test plates were maintained at 30°C by partial submersion in a water bath.At timed intervals for bacteria and fungi, the aliquots were plated out by using a WASP spiral plater and colonies subsequently counted by using a ProtoCOL automated colony counter (Don Whitley, West Yorkshire, United Kingdom). Acanthamoeba trophozoite and cyst viabilities were determined as described previously (6). Statistical analysis was performed using a one-way analysis of variance (ANOVA) of data from triplicate experiments via the InStat statistical software package (GraphPad, La Jolla, CA).The efficacies of simulated sunlight at an optical output irradiance of 150 W m−2 alone (SODIS) and in the presence of 250 μM riboflavin (SODIS-R) against the test organisms are shown in Table Table1.1. With the exception of B. subtilis spores and A. polyphaga cysts, SODIS-R resulted in a significant increase in microbial killing compared to SODIS alone (P < 0.001). In most instances, SODIS-R achieved total inactivation by 2 h, compared to 6 h for SODIS alone (Table (Table1).1). For F. solani, C. albicans, ands A. polyphaga trophozoites, only SODIS-R achieved a complete organism kill after 4 to 6 h (P < 0.001). All control experiments in which the experiments were protected from the light source showed no reduction in organism viability over the time course (results not shown).

TABLE 1.

Efficacies of simulated SODIS for 6 h alone and with 250 μM riboflavin (SODIS-R)
OrganismConditionaLog10 reduction in viability at indicated h of exposureb
1246
E. coliSODIS0.0 ± 0.00.2 ± 0.15.7 ± 0.05.7 ± 0.0
SODIS-R1.1 ± 0.05.7 ± 0.05.7 ± 0.05.7 ± 0.0
L. pneumophilaSODIS0.7 ± 0.21.3 ± 0.34.8 ± 0.24.8 ± 0.2
SODIS-R4.4 ± 0.04.4 ± 0.04.4 ± 0.04.4 ± 0.0
P. aeruginosaSODIS0.7 ± 0.01.8 ± 0.04.9 ± 0.04.9 ± 0.0
SODIS-R5.0 ± 0.05.0 ± 0.05.0 ± 0.05.0 ± 0.0
S. aureusSODIS0.0 ± 0.00.0 ± 0.06.2 ± 0.06.2 ± 0.0
SODIS-R0.2 ± 0.16.3 ± 0.06.3 ± 0.06.3 ± 0.0
C. albicansSODIS0.2 ± 0.00.4 ± 0.10.5 ± 0.11.0 ± 0.1
SODIS-R0.1 ± 0.00.7 ± 0.15.3 ± 0.05.3 ± 0.0
F. solani conidiaSODIS0.2 ± 0.10.3 ± 0.00.2 ± 0.00.7 ± 0.1
SODIS-R0.3 ± 0.10.8 ± 0.11.3 ± 0.14.4 ± 0.0
B. subtilis sporesSODIS0.3 ± 0.00.2 ± 0.00.0 ± 0.00.1 ± 0.0
SODIS-R0.1 ± 0.10.2 ± 0.10.3 ± 0.30.1 ± 0.0
SODIS (250 W m−2)0.1 ± 0.00.1 ± 0.10.1 ± 0.10.0 ± 0.0
SODIS-R (250 W m−2)0.0 ± 0.00.0 ± 0.00.2 ± 0.00.4 ± 0.0
SODIS (320 W m−2)0.1 ± 0.10.1 ± 0.00.0 ± 0.14.3 ± 0.0
SODIS-R (320 W m−2)0.1 ± 0.00.1 ± 0.10.9 ± 0.04.3 ± 0.0
A. polyphaga trophozoitesSODIS0.4 ± 0.20.6 ± 0.10.6 ± 0.20.4 ± 0.1
SODIS-R0.3 ± 0.11.3 ± 0.12.3 ± 0.43.1 ± 0.2
SODIS, naturalc0.3 ± 0.10.4 ± 0.10.5 ± 0.20.3 ± 0.2
SODIS-R, naturalc0.2 ± 0.11.0 ± 0.22.2 ± 0.32.9 ± 0.3
A. polyphaga cystsSODIS0.4 ± 0.10.1 ± 0.30.3 ± 0.10.4 ± 0.2
SODIS-R0.4 ± 0.20.3 ± 0.20.5 ± 0.10.8 ± 0.3
SODIS (250 W m−2)0.0 ± 0.10.2 ± 0.30.2 ± 0.10.1 ± 0.2
SODIS-R (250 W m−2)0.4 ± 0.20.3 ± 0.20.8 ± 0.13.5 ± 0.3
SODIS (250 W m−2), naturalc0.0 ± 0.30.2 ± 0.10.1 ± 0.10.2 ± 0.1
SODIS-R (250 W m−2), naturalc0.1 ± 0.10.2 ± 0.20.6 ± 0.13.4 ± 0.2
Open in a separate windowaConditions are at an intensity of 150 W m−2 unless otherwise indicated.bThe values reported are means ± standard errors of the means from triplicate experiments.cAdditional experiments for this condition were performed using natural freshwater.The highly resistant A. polyphaga cysts and B. subtilis spores were unaffected by SODIS or SODIS-R at an optical irradiance of 150 W m−2. However, a significant reduction in cyst viability was observed at 6 h when the optical irradiance was increased to 250 W m−2 for SODIS-R only (P < 0.001; Table Table1).1). For spores, a kill was obtained only at 320 W m−2 after 6-h exposure, and no difference between SODIS and SODIS-R was observed (Table (Table1).1). Previously, we reported a >2-log kill at 6 h for Acanthamoeba cysts by using SODIS at the higher optical irradiance of 850 W m−2, compared to the 0.1-log10 kill observed here using the lower intensity of 250 W m−2 or the 3.5-log10 kill with SODIS-R.Inactivation experiments performed with Acanthamoeba cysts and trophozoites suspended in natural freshwater gave results comparable to those obtained with Ringer''s solution (P > 0.05; Table Table1).1). However, it is acknowledged that the findings of this study are based on laboratory-grade water and freshwater and that differences in water quality through changes in turbidity, pH, and mineral composition may significantly affect the performance of SODIS (20). Accordingly, further studies are indicated to evaluate the enhanced efficacy of SODIS-R by using natural waters of varying composition in the areas where SODIS is to be employed.Previous studies with SODIS under laboratory conditions have employed lamps delivering an optical irradiance of 850 W m−2 to reflect typical natural sunlight conditions (6, 11, 12, 15, 16). Here, we used an optical irradiance of 150 to 320 W m−2 to obtain slower organism inactivation and, hence, determine the potential enhancing effect of riboflavin on SODIS.In conclusion, this study has shown that the addition of riboflavin significantly enhances the efficacy of simulated SODIS against a range of microorganisms. The precise mechanism by which photoactivated riboflavin enhances antimicrobial activity is unknown, but studies have indicated that the process may be due, in part, to the generation of singlet oxygen, H2O2, superoxide, and hydroxyl free radicals (10). Further studies are warranted to assess the potential benefits from riboflavin-enhanced SODIS in reducing the incidence of gastrointestinal infection in communities where potable water is not available.  相似文献   

16.
Detection and Identification of tdh- and trh-Positive Vibrio parahaemolyticus Strains from Four Species of Cultured Bivalve Molluscs on the Spanish Mediterranean Coast     
Ana Roque  Carmen Lopez-Joven  Beatriz Lacuesta  Laurence Elandaloussi  Sariqa Wagley  M. Dolores Furones  Imanol Ruiz-Zarzuela  Ignacio de Blas  Rachel Rangdale  Bruno Gomez-Gil 《Applied and environmental microbiology》2009,75(23):7574-7577
Presented here is the first report describing the detection of potentially diarrheal Vibrio parahaemolyticus strains isolated from cultured bivalves on the Mediterranean coast, providing data on the presence of both tdh- and trh-positive isolates. Potentially diarrheal V. parahaemolyticus strains were isolated from four species of bivalves collected from both bays of the Ebro delta, Spain.Gastroenteritis caused by Vibrio parahaemolyticus has been reported worldwide, though only sporadic cases have been reported in Europe (7, 14). The bacterium can be naturally present in seafood, but pathogenic isolates capable of inducing gastroenteritis in humans are rare in environmental samples (2 to 3%) (15) and are often not detected (10, 19, 20).The virulence of V. parahaemolyticus is based on the presence of a thermostable direct hemolysin (tdh) and/or the thermostable direct hemolysin-related gene (trh) (1, 5). Both are associated with gastrointestinal illnesses (2, 9).Spain is not only the second-largest producer in the world of live bivalve molluscs but also one of the largest consumers of bivalve molluscs, and Catalonia is the second-most important bivalve producer of the Spanish Autonomous Regions. Currently, the cultivation of bivalves in this area is concentrated in the delta region of the Ebro River. The risk of potentially pathogenic Vibrio spp. in products placed on the market is not assessed by existing legislative indices of food safety in the European Union, which emphasizes the need for a better knowledge of the prevalence of diarrheal vibrios in seafood products. The aim of this study was to investigate the distribution and pathogenic potential of V. parahaemolyticus in bivalve species exploited in the bays of the Ebro delta.Thirty animals of each species of Mytilus galloprovincialis, Crassostrea gigas, Ruditapes decussatus, and Ruditapes philippinarum were collected. They were sampled from six sites of the culture area, three in each bay of the Ebro River delta, at the beginning (40°37′112"N, 0°37′092"E [Alfacs]; 40°46′723"N, 0°43′943"E [Fangar]), middle (40°37′125"N, 0°38′570"E [Alfacs]; 40°46′666"N, 0°45′855"E [Fangar]), and end (40°37′309"N, 0°39′934"E [Alfacs]; 40°46′338"N, 0°44′941"E [Fangar]) of the culture polygon. Clams were sampled from only one site per bay as follows: in the Alfacs Bay from a natural bed of R. decussatus (40°37′44"N, 0°38′0"E) and in the Fangar Bay from an aquaculture bed of R. philippinarum (40°47′3"N, 0°43′8"E). In total, 367 samples were analyzed in 2006 (180 oysters, 127 mussels, 30 carpet shell clams, and 30 Manila clams) and 417 samples were analyzed in 2008 (178 oysters, 179 mussels, 30 carpet shell clams, and 30 Manila clams).All animals were individually processed and homogenized, and 1 ml of the homogenate was inoculated into 9 ml of alkaline peptone water (Scharlau, Spain). Following a 6-h incubation at 37°C, one loopful of the contents of each tube of alkaline peptone water was streaked onto CHROMagar vibrio plates (CHROMagar, France) and incubated for 18 h at 37°C. Mauve-purple colonies were purified, and each purified isolate was cryopreserved at −80°C (135 isolates in 2006 and 96 in 2008). From the initial homogenate portion, 100 μl was inoculated onto marine agar (Scharlau, Spain) and onto thiosulfate citrate-bile salts-sucrose agar (Scharlau, Spain) for total heterotrophic marine bacteria counts and total vibrio counts, respectively (Table (Table11).

TABLE 1.

Vibrio parahaemolyticus isolates, serotypes, and origins and total number of vibrios/heterotrophic bacteria contained in the bivalvea
IsolateDate of collectionOrganism and site of originTemp (°C)Salinity (‰)Gene(s)SerotypeBacterial count using indicated medium (CFU ml−1)
TCBS agarMarine agar
I7458 August 2006Mg-F24.537tdhND1.5 × 1041.2 × 104
I79314 August 2006Cg-A2535tdhND9.2 × 1028.5 × 103
I80514 August 2006Cg-A2535tdhO2:KUT7.2 × 1029 × 103
I80614 August 2006Cg-A2535tdh and trhO3:K331.9 × 1034.6 × 103
I80914 August 2006Cg-A2535tdhO2:K288 × 1047.3 × 102
I6784 July 2006Rd-A28.636tdhO2:K283.1 × 1052.5 × 105
I6284 July 2006Rd-A28.636tdhO4:KUT2.9 × 1048.4 × 104
I7758 August 2006Cg-A24.537tdhND4.21 × 1031.1 × 104
I6914 July 2006Rd-A28.636trhO1:K322.2 × 1052.6 × 105
I71227 July 2006Mg-A29.435.5trhO1:KUT8.6 × 1038.4 × 103
I7658 August 2006Cg-F24.537trhO4:K341 × 104Uncountable
I98022 July 2008Cg-A26.733.5tdhO1:K322.7 × 1041.3 × 104
I98122 July 2008Cg-A26.733.5trhO1:KUT1 × 1042.2 × 104
I99322 July 2008Cg-A26.733.5tdhO5:K173 × 1031.1 × 104
I99429 July 2008Mg-A27.737trhO3:KUT3.4 × 1037 × 103
I10315 August 2008Cg-F27.737tdhO5:KUT5.5 × 1043.3 × 104
I10345 August 2008Cg-F27.737tdhO3:KUT8.7 × 1044 × 104
I10405 August 2008Cg-F27.737tdhO3:KUT1.6 × 1043.2 × 104
I10425 August 2008Cg-F27.737tdh and trhND2.8 ×1043 × 104
I10505 August 2008Cg-F27.737tdhO1:KUT4.7 × 1047.3 × 104
I106320 August 2008Mg-F25.936tdhO3:KUT7.9 ×1041.4 × 104
I106520 August 2008Mg-F25.936tdhO2:KUT2.2 × 1031.2 × 104
I106820 August 2008Mg-F25.936tdhO5:KUT2.6 × 1045.2 × 104
I106920 August 2008Mg-F25.936tdhO3:KUT2.4 × 1035.3 × 104
I107320 August 2008Mg-F25.936tdhO5:KUT2.3 × 1037.5 × 103
I107420 August 2008Mg-F25.936tdhO3:KUT7.6 × 1046.9 × 104
I107720 August 2008Mg-F25.936tdhO4:KUT1.7 × 1031.6 × 103
I107920 August 2008Mg-F25.936trhO3:KUT2.5 × 1031.1 × 104
I109220 August 2008Mg-F25.936tdhND1.7 × 1031.6 × 103
I113025 August 2008Rd-A26.435tdhND1.7 × 1043.8 × 104
I114325 August 2008Rd-A26.435tdhND1.1 × 1041.9 × 104
I116525 August 2008Rd-A26.435trhO2:KUT4.4 × 1046.8 × 104
I113325 August 2008Rp-F25.536.5tdhND3.4 × 1044 × 104
I113425 August 2008Rp-F25.536.5tdhND3.9 × 1045.8 × 104
I115825 August 2008Rp-F25.536.5trhO4:KUT6.6 × 1044.7 × 104
I116125 August 2008Rp-F25.536.5trhO3:KUT2.2 × 1046.6 × 104
Open in a separate windowaMg, Mytilus galloprovincialis; Cg, Crassostrea gigas; Rd, Ruditapes decussatus; Rp, R. phillipinarum; A, Alfacs; F, Fangar; ND, not determined; TCBS, thiosulfate citrate-bile salts-sucrose.Total DNA was extracted from each purified isolate using the Wizard genomic DNA purification kit (Promega), following the instructions of the manufacturer. A one-step PCR analysis was performed to identify/confirm which isolates were tl positive (species marker for V. parahaemolyticus). Further detection of the tdh or trh gene was carried out on all positive tl strains. All PCR analyses were carried out using the primers described by Bej et al. (2) with the following amplification conditions on the thermocycler (Eppendorf Mastercycler Personal): an initial denaturation at 95°C for 8 min, followed by 40 cycles of a 1-min denaturation at 94°C, annealing at 55°C for 1 min, elongation at 72° for 1 min, and a final extension of 10 min at 72°C. Positive and negative controls were included in all reaction mixtures: two positive controls, tl and tdh CAIM 1400 and trh CAIM 1772 (Collection of Aquatic Important Microorganisms [http://www.ciad.mx/caim/CAIM.html]), and negative control DNA-free molecular grade water (Sigma-Aldrich, Spain). Expected amplicons were visualized in 2% agarose gels stained with ethidium bromide.Fifty-eight isolates contained the gene tl in 2006 and 96 in 2008, which confirmed their identity as V. parahaemolyticus. In 2006, the distribution of the 58 isolates was as follows: 7 from 127 mussels, 34 from 180 oysters, and 17 from 30 R. decussatus clams. No tl-positive isolates were found in R. philippinarum. PCR analysis of the tl-positive isolates for the presence of the tdh or trh gene indicated that eight isolates contained the tdh gene and four contained the trh gene. In 2008, the source of the confirmed V. parahaemolyticus isolates was as follows: 31 from 88 oysters, 44 from 89 mussels, 9 from 30 R. decussatus clams, and 12 from 30 R. philippinarum clams. Of these, 17 were found to contain the tdh gene and 7 contained the trh gene. Two isolates (I806 and I1042) contained both toxigenic genes, tdh and trh.Putative tdh- and trh-positive PCR products were purified using the QIAquick PCR purification kit (Qiagen) following the manufacturer''s instructions and were sequenced bidirectionally by Macrogen Inc. Sequences were aligned using BioEdit (8) and analyzed using BLAST (National Center for Biotechnology Information). None of the toxigenic isolates was found positive by PCR analysis for the presence of open reading frame 8 of the phage 237 (16), a marker for the pandemic strain O3:K6.The isolates were fingerprinted by repetitive extragenic palindromic PCR (rep-PCR) as described previously (3), and the resulting electrophoretic band patterns were analyzed with the GelCompar II software (v4.5; Applied Maths). The similarity matrix was calculated with the Jaccard coefficient with a band position tolerance of 0.8%, and the dendrogram was constructed with the Ward algorithm. A high level of genomic diversity was found among the 32 toxigenic isolates characterized by rep-PCR. Three clonal groups were identified (those having identical rep-PCR band patterns) (Fig. 1a to c).Open in a separate windowFIG. 1.rep-PCR dendrogram of toxigenic isolates of V. parahaemolyticus isolated in the Ebro delta. Letters denote clonal groups of isolates.In vitro antibiotic susceptibility tests were performed using the diffusion disc test following a previously described protocol (18). The antibiotics used were gentamicin (10 μg), oxolinic acid (10 μg), amoxicillin (25 μg), polymyxin B (300 UI), vancomycin (30 μg), trimethoprim sulfamethoxazole (1.25/23.75 μg), nitrofurantoin (300 μg), doxycyclin (30 μg), ceftazidime (30 μg), streptomycin (10 μg), neomycin (30 UI), penicillin (6 μg), flumequine (30 μg), tetracycline (30 μg), ampicillin (10 μg), kanamycin (30 μg), ciprofloxacin (5 μg), and sulfonamide (300 μg). All tests were performed in duplicate. A Student t test for two samples with unequal variance was performed to compare the sensitivity of all 2006 isolates against the sensitivity of 2008 isolates for each antibiotic (Microsoft Office Excel 97-2003). Antibiogram results revealed a lower susceptibility in 2008 than in 2006, indicating a possible shift in overall susceptibility. Results from the t test indicated that significantly lower susceptibility in 2008 was detected (P ≤ 0.05; n = 36) for the following antibiotics: vancomycin, polymyxin B, ampicillin, amoxicillin, gentamicin, neomycin, trimethoprim sulfamethoxazole, nitrofurantoin, doxycyclin, ceftazidime, tetracycline, flumequine, and ciprofloxacin.The serological types for 27 strains were determined by the agglutination method using commercially available V. parahaemolyticus antisera (Denka Seiken Ltd.; Cosmos Biomedical Ltd, United Kingdom) following the manufacturer''s instructions. Potentially toxigenic V. parahaemolyticus isolates collected in 2006 were serologically heterogeneous (8 out of the 11 isolates) (Table (Table1).1). In isolates collected in 2008, results were more homogenous, with seven serotypes found among 19 isolates analyzed. The O3:K6 serotype was not detected in any of the strains analyzed, in agreement with the open reading frame 8 PCR results.The present study is the first to report the detection of potentially diarrheal V. parahaemolyticus strains isolated from cultured bivalves on Spanish Mediterranean coasts, providing data on the presence of both tdh- and trh-positive isolates. V. parahaemolyticus has previously been detected in several European countries (4, 13, 21, 22). A recent study carried out in Spain detected tdh-positive V. parahaemolyticus strains from patients who had consumed fresh oysters in a market in Galicia on the Atlantic coast of Spain (12) and potentially pathogenic V. parahaemolyticus strains have also been reported in France (17). These studies indicate that the risk of infections caused by V. parahaemolyticus in Europe is low compared to that in America or Asia (15). However, this risk could have been underestimated, since V. parahaemolyticus is not included in the current European surveillance programs, such as the European Network for Epidemiological Surveillance and Control of Communicable Diseases.Toxigenic V. parahaemolyticus strains detected in this study were genomically and serologically heterogeneous. The pandemic serotype O3:K6 was not detected, and although attempts to isolate O3:K6 from the environment and from seafood have not always been successful in previous studies reviewed by Nair and coauthors (15), this finding seems to be in agreement with the fact that no outbreak of diarrhea was observed in the area. Interestingly, isolates I806 and I1042 have been found positive for both tdh and trh in PCR tests. The coexistence of tdh and trh genes has already been reported in isolates from Japan, the United States, and Mexico (3, 6, 11, 19, 23). To our knowledge, no occurrence of an environmental isolate positive for both tdh and trh had previously been reported in Europe. All isolates tested were slightly different in their antibiotic resistance profiles. Typically, a high level of resistance could be determined. The detection of tdh- and/or trh-positive V. parahaemolyticus strains for the first time on the Mediterranean coast emphasizes the need to monitor for the presence of potentially diarrheal vibrios and bacterial gastroenteritis, and these data should be taken into consideration to revise the European legislation on the requirements for shellfish harvested for consumption in order to include the surveillance of these pathogens in Europe.  相似文献   

17.
Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation     
Fengzhen Yang  Qi Zhao  Lipeng Wang  Jinying Wu  Lihua Jiang  Li Sheng  Leyan Zhang  Zhaoping Xue  Maoli Yi 《Polish journal of microbiology》2022,71(2):251
Cefoperazone/sulbactam (CSL) and piperacillin/tazobactam (TZP) are commonly used in clinical practice in China because of their excellent antimicrobial activity. CSL and TZP-nonsusceptible Enterobacteriaceae are typically resistant to extended-spectrum cephalosporins such as ceftriaxone (CRO). However, 11 nonrepetitive Enterobacteriaceae strains, which were resistant to CSL and TZP yet susceptible to CRO, were collected from January to December 2020. Antibiotic susceptibility tests and whole-genome sequencing were conducted to elucidate the mechanism for this rare phenotype. Antibiotic susceptibility tests showed that all isolates were amoxicillin/clavulanic-acid resistant and sensitive to ceftazidime, cefepime, cefepime/tazobactam, cefepime/zidebactam, ceftazidime/avibactam, and ceftolozane/tazobactam. Whole-genome sequencing revealed three of seven Klebsiella pneumoniae strains harbored blaSHV-1 only, and four harbored blaSHV-1 and blaTEM-1B. Two Escherichia coli strains carried blaTEM-1B only, while two Klebsiella oxytoca isolates harbored blaOXY-1-3 and blaOXY-1-1, respectively. No mutation in the β-lactamase gene and promoter sequence was found. Outer membrane protein (Omp) gene detection revealed that numerous missense mutations of OmpK36 and OmpK37 were found in all strains of K. pneumoniae. Numerous missense mutations of OmpK36 and OmpK35 and OmpK37 deficiency were found in one K. oxytoca strain, and no OmpK gene was found in the other. No Omp mutations were found in E. coli isolates. These results indicated that narrow spectrum β-lactamases, TEM-1, SHV-1, and OXY-1, alone or in combination with Omp mutation, contributed to the resistance to CSL and TZP in CRO-susceptible Enterobacteriaceae.Antibiotic susceptibility tests
AntibioticsBreakpoint, (μg/ml)Klebsiella pneumoniae
Escherichia cou
Klebriehd axyoca
E1E3E4E7E9E10E11E6E8E2E5
CRO≤1≥4≤0.5≤0.5≤0.5≤0.5 1≤0.51≤0.5≤0.511
CAZ4 ≥161214444241 1
FEP≤2 216 110.2512220.521 1
AMC≤8 ≥32≥128≥128≥128≥128≥128≥128≥128≥128≥128≥128≥128
CSL≤16 ≥6464646464≥128128≥12864128128≥128
TZP≤16 ≥128≥256≥256≥256≥25622562256≥256≥256≥256≥256≥256
FPT≤2 ≥1610.50.060.1252120.2510.1250.25
FPZ≤2 2160.250.250.060.1250.250.25 10.1250.250.1250.125
CZA≤8 216 10.50.250.2510.2510.50.50.50.25
CZT≤2 28210.5 1222 1122
Open in a separate windowCROceftriaxone, CAZceftazidime, FEPcefepime, AMC:amoxicillin clavulanic-acid, CSLcefoperazone/sulbactam, TZP:piperadllin/tazobactam, FPT:cefepime tazobactam, FPZ:cefepime/zidebactam, CZA:ceftazidime/avibactam, CZTceftolozane/tazobactam Gene sequencing results
NumberStrainSTp-Lactamase genePromoter sequence mutationOmp mutation
ElKpn45blaSHV-1, blaTEM-lBnoneOmpK36, OmpK3 7
E3Kpn45blaSHV-1, blaTEM-lBnoneOmpK36. OmpK3 7
E4Kpn2854blaSHV-1noneOmpK36, OmpK3 7
E7Kpn2358blaSHV-1 - blaTEM-lBnoneOmpK36, OmpK3 7
E9Kpn2358blaSHV-1. blaTEM-lBnoneOmpK36. OmpK3 7
E10Kpn 189blaSHV-1noneOmpK36. OmpK3 7
EllKpn45blaSHV-1noneOmpK36, OmpK3 7
E6Eco88blaTEM-lBnonenone
ESEco409blaTEM-1Bnonenone
E2Kox194blaOXY-1-3noneOmpK36 mutations. OmpK35 and OmpK 37 deficiency
E5Kox 11blaOXY-1-1noneno OmpK (OmpK3 5, OmpK36 and OmpK37) gene found
Open in a separate window  相似文献   

18.
Identification of Pathogenic Vibrio Species by Multilocus PCR-Electrospray Ionization Mass Spectrometry and Its Application to Aquatic Environments of the Former Soviet Republic of Georgia     
Chris A. Whitehouse  Carson Baldwin  Rangarajan Sampath  Lawrence B. Blyn  Rachael Melton  Feng Li  Thomas A. Hall  Vanessa Harpin  Heather Matthews  Marina Tediashvili  Ekaterina Jaiani  Tamar Kokashvili  Nino Janelidze  Christopher Grim  Rita R. Colwell  Anwar Huq 《Applied and environmental microbiology》2010,76(6):1996-2001
  相似文献   

19.
Environmental Isolates of Burkholderia pseudomallei in Ceará State,Northeastern Brazil     
Dione B. Rolim  Marcos F. G. Rocha  Raimunda S. N. Brilhante  Rossana A. Cordeiro  Natanael P. Leit?o-Junior  Timothy J. J. Inglis  José J. C. Sidrim 《Applied and environmental microbiology》2009,75(4):1215-1218
Melioidosis has been considered an emerging disease in Brazil since the first cases were reported to occur in the northeast region. This study investigated two municipalities in Ceará state where melioidosis cases have been confirmed to occur. Burkholderia pseudomallei was isolated in 26 (4.3%) of 600 samples in the dry and rainy seasons.Melioidosis is an endemic disease in Southeast Asia and northern Australia (2, 4) and also occurs sporadically in other parts of the world (3, 7). Human melioidosis was reported to occur in Brazil only in 2003, when a family outbreak afflicted four sisters in the rural part of the municipality of Tejuçuoca, Ceará state (14). After this episode, there was one reported case of melioidosis in 2004 in the rural area of Banabuiú, Ceará (14). And in 2005, a case of melioidosis associated with near drowning after a car accident was confirmed to occur in Aracoiaba, Ceará (11).The goal of this study was to investigate the Tejuçuoca and Banabuiú municipalities, where human cases of melioidosis have been confirmed to occur, and to gain a better understanding of the ecology of Burkholderia pseudomallei in this region.We chose as central points of the study the residences and surrounding areas of the melioidosis patients in the rural areas of Banabuiú (5°18′35″S, 38°55′14″W) and Tejuçuoca (03°59′20″S, 39°34′50′W) (Fig. (Fig.1).1). There are two well-defined seasons in each of these locations: one rainy (running from January to May) and one dry (from June to December). A total of 600 samples were collected at five sites in Tejuçuoca (T1, T2, T3, T4, and T5) and five in Banabuiú (B1, B2, B3, B4, and B5), distributed as follows (Fig. (Fig.2):2): backyards (B1 and T1), places shaded by trees (B2 and T2), water courses (B3 and T3), wet places (B4 and T4), and stock breeding areas (B5 and T5).Open in a separate windowFIG. 1.Municipalities of Banabuiú (5°18′35″S, 38°55′14″W) and Tejuçuoca (03°59′20″S, 39°34′50″W).Open in a separate windowFIG. 2.Soil sampling sites in Banabuiú and Tejuçuoca.Once a month for 12 months (a complete dry/rainy cycle), five samples were gathered at five different depths: at the surface and at 10, 20, 30 and 40 cm (Table (Table1).1). The samples were gathered according to the method used by Inglis et al. (9). Additionally, the sample processing and B. pseudomallei identification were carried out as previously reported (1, 8, 9).

TABLE 1.

Distribution of samples with isolates by site and soil depth
Sitesa and depth (cm)No. of B. pseudomallei isolates in samples from:
Banabuiú (n = 300)Tejuçuoca (n = 300)Total (n = 600)
B1/T13
    Surface2
    10
    201
    30
    40
B2/T21
    Surface1
    10
    20
    30
    40
B3/T315
    Surface2
    102
    204
    303
    404
B4/T45
    Surface
    101
    201
    3011
    401
B5/T52
    Surface
    10
    20
    302
    40
Total62026
Open in a separate windowaSites designated with B are in Banabuiú, and sites designated with T are in Tejuçuoca. See the text for details.The data on weather and soil composition were obtained from specialized government institutions, such as FUNCEME, IPECE, and EMBRAPA. The average annual temperature in both municipalities is between 26 and 28°C. In 2007, the annual rainfall in Tejuçuoca was 496.8 mm, and that in Banabuiú was 766.8 mm. There are a range of soil types in both Tejuçuoca and Banabuiú: noncalcic brown, sodic planossolic, red-yellow podzolic, and litholic. In Banabuiú, there are also alluvial and cambisol soils. The characteristic vegetation in both municipalities is caatinga (scrublands).There were isolates of B. pseudomallei in 26 (4.3%) of the 600 samples collected. The bacterium was isolated at a rate (3%) similar to that previously reported (9). The bacterium isolation occurred in both the dry (53.8%) and the rainy (46.2%) seasons. Tejuçuoca represented 76.9% (20/26) of the strains isolated. Four sites in Tejuçuoca (T1, T3, T4, and T5) and three in Banabuiú (B1, B2, and B4) presented isolates of the bacterium (Table (Table1).1). The isolation of the B. pseudomallei strains varied from the surface down to 40 cm. However, 17 of the 26 positive samples (65.3%) were found at depths between 20 and 40 cm (Table (Table1).1). Only two isolates were found at the surface during the dry season.A study in Vietnam (13) and one in Australia (9) reported the presence of B. pseudomallei near the houses of melioidosis patients. In our study, the same thing happened. Site T3 (15/26; 57.6%) was located 290 m from the patient''s house, as reported by the Rolim group (14).B. pseudomallei was isolated from a sheep paddock in Australia, where animals sought shelter below mango and fig trees (17). In our study, the bacterium was isolated at site T5, a goat corral alongside the house where the outbreak occurred in Tejuçuoca. Four sites in places shaded by trees yielded positive samples (30.7%) in both Tejuçuoca (palm trees) and Banabuiú (mango trees). Additionally, B. pseudomallei was isolated on three occasions from a cornfield (site 4B) located alongside the house of the melioidosis patient in Banabuiú.In the main areas of endemicity, the disease is more prevalent in the rainy season (4, 5, 16). The outbreak in Tejuçuoca was related to rainfall (14). Besides the association of cases of the disease with rainfall itself, the isolation of B. pseudomallei in soil and water was also demonstrated during the dry season (12, 15). An Australian study isolated strains from soil and water during the dry and rainy seasons (17). A Thai study also reported B. pseudomallei in the dry season (18). In our study, the isolation of B. pseudomallei took place either at the end of the wet season or in the dry months. Fourteen of the positive samples (53.8%) were collected during the dry season, albeit near a river or reservoir (sites T3 and B4).Physical, biological, and chemical soil features appear to influence the survival of B. pseudomallei (6, 10). In the present study, the soil was classified as litholic with sandy or clayey textures. It is susceptible to erosion, and when there is a lack of water, it is subject to salinization. During the dry season, the clay layer becomes dried, cracked, and very hard. During the rainy season, it becomes soggy and sticky. The isolation of B. pseudomallei in the dry season is possibly related to the capacity for adaptation of this soil, since the extreme conditions of lithosols do not prevent the bacterial growth and survival.It has been shown that B. pseudomallei is more often isolated at depths between 25 and 45 cm (17). In our study, 65.3% of the positive samples were taken at depths between 20 and 40 cm. Moreover, of these 17 samples, 10 (58.8%) were collected during the dry months. Also, unlike in other regions, two positive samples were taken from the surface in the period without rainfall.The rainfall in Tejuçuoca and Banabuiú is generally low, and temperatures do not vary significantly during the year. Therefore, the isolation of B. pseudomallei in these places occurs outside the rainfall, temperature, and moisture conditions observed in other regions of endemicity. Our data thus suggest that peculiar environmental features, such as soil composition, might favor the multiplication of B. pseudomallei in northeast Brazil.  相似文献   

20.
Costos directos de la infección adquirida en la comunidad por neonatos a término con bajo riesgo al nacer,Cundinamarca, Colombia     
Sergio Ivn Agudelo  Carlos Federico Molina   scar Andrs Gamboa  Juan David Surez 《Biomédica : revista del Instituto Nacional de Salud》2021,41(1):87
IntroducciónEl 50% de los episodios de sepsis neonatal se originan en la comunidad, con un gran porcentaje de mortalidad y complicaciones.ObjetivoEstimar los costos directos de la hospitalización por infección neonatal adquirida en la comunidad en neonatos a término con bajo riesgo al nacer.Materiales y métodosSe utilizó la perspectiva del tercer pagador y la técnica de microcosteo; el horizonte de tiempo fue la duración de la hospitalización. La determinación de las situaciones generadoras de costos se obtuvo por medio de un consenso de expertos y se cuantificaron con base en la factura detallada de la atención de 337 neonatos hospitalizados. Los costos de los medicamentos se calcularon con base en el Sistema de Información de Precios de Medicamentos (SISMED) y, el de los procedimientos, según los manuales tarifarios ISS 2001 con porcentaje de ajuste y el seguro obligatorio de accidentes de tráfico (SOAT). Para incorporar la variabilidad de la información en la estimación, se obtuvo una distribución de los costos usando el método de bootstrapping.ResultadosSe incluyeron las facturas por la atención de 337 recién nacidos. El promedio de costos directos de la atención por paciente fue de COL$ 2’773.965 (desviación estándar, DE=$ 198.813,5; IC95%: $ 2’384.298 - $ 3’163.632). Las principales categorías generadoras de costos fueron la internación en la unidad de cuidados intensivos y las tecnologías en salud. Los costos siguieron una una distribución logarítmica normal (log-normal).ConclusionesLas categorías con mayor impacto en los costos fueron la internación en la unidad neonatal y las tecnologías en salud. Los costos se ajustaron a una distribución logarítmica normal.Palabras clave: sepsis neonatal, costos y análisis de costo, recién nacido, unidades de cuidado intensivo neonatal, mortalidad infantil  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号